Pharming Group N.V (PHAR) Cash from Operations: 2020-2022
Historic Cash from Operations for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2022 value amounting to $609,000.
- Pharming Group N.V's Cash from Operations fell 91.38% to $609,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $626,223, marking a year-over-year decrease of 91.16%. This contributed to the annual value of $37,759 for FY2021, which is 99.95% down from last year.
- According to the latest figures from Q4 2022, Pharming Group N.V's Cash from Operations is $609,000, which was up 113.27% from -$4.6 million recorded in Q3 2022.
- Pharming Group N.V's 5-year Cash from Operations high stood at $21.3 million for Q4 2020, and its period low was -$16.4 million during Q3 2021.
- For the 3-year period, Pharming Group N.V's Cash from Operations averaged around $4.6 million, with its median value being $2.3 million (2022).
- Per our database at Business Quant, Pharming Group N.V's Cash from Operations crashed by 195.57% in 2021 and then soared by 8,524.84% in 2022.
- Quarterly analysis of 3 years shows Pharming Group N.V's Cash from Operations stood at $21.3 million in 2020, then slumped by 66.88% to $7.1 million in 2021, then slumped by 91.38% to $609,000 in 2022.
- Its Cash from Operations was $609,000 in Q4 2022, compared to -$4.6 million in Q3 2022 and $4.0 million in Q2 2022.